Group 1 - The company, Chengzhi Co., stated that it conducts annual impairment tests on goodwill in accordance with the "Enterprise Accounting Standards" and other relevant regulations [2] - The results of the impairment tests determine whether the company needs to recognize goodwill impairment provisions [2]

Core Viewpoint - Tianji Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure regulations, but the company asserts that its production and operational activities remain normal and unaffected by the investigation [2][4]. Group 1: Regulatory Actions - The CSRC has decided to initiate a case against Tianji Co., Ltd. due to issues related to improper goodwill impairment testing, inaccurate financial accounting, and non-compliance with information disclosure regulations [2][4]. - The Guangdong Regulatory Bureau issued an administrative regulatory decision, citing the company's failure to adhere to the "Management Measures for Information Disclosure of Listed Companies" [5]. - The Shenzhen Stock Exchange has also issued a regulatory letter to Tianji Co., Ltd. regarding the same violations [5]. Group 2: Company Response - Tianji Co., Ltd. has expressed its commitment to cooperate with the CSRC and to rectify the identified issues by implementing corrective measures and submitting a written report to the regulatory authorities [6]. - The company plans to enhance its understanding of relevant laws and regulations, improve its internal control systems, and elevate the quality of its information disclosure to protect the interests of shareholders [6]. Group 3: Financial and Shareholder Information - As of February 11, the stock price of Tianji Co., Ltd. was reported at 43.96 yuan per share, with a total market capitalization of 22 billion yuan [7]. - As of January 30, the company had over 180,000 shareholders, reflecting a 2.02% increase in the number of shareholders compared to the previous period [9][10].

Core Viewpoint - Tianji Co., Ltd. is currently under investigation by the China Securities Regulatory Commission (CSRC) for issues related to goodwill impairment testing, inaccurate financial accounting, and non-compliance with information disclosure regulations. The company asserts that these matters will not significantly impact its normal production and operational activities [2][3]. Group 1: Regulatory Actions - On January 15, Tianji Co., Ltd. received an administrative regulatory decision from the Guangdong Regulatory Bureau of the CSRC, citing non-compliance in goodwill impairment testing, financial accounting inaccuracies, and improper information disclosure [2]. - The CSRC has mandated corrective administrative measures for Tianji Co., Ltd. and issued warning letters to key executives, including Chairman Wu Xidun, CFO Yang Zhixuan, and Board Secretary Zheng Wenlong, for their failure to fulfill their duties [2][3]. - The Shenzhen Stock Exchange has also issued a regulatory letter to Tianji Co., Ltd., highlighting similar violations, including improper goodwill impairment testing and failure to appropriately account for employee compensation [3]. Group 2: Company Response - Tianji Co., Ltd. has expressed its commitment to addressing the issues raised in the regulatory documents by conducting self-examinations, formulating corrective measures, and submitting written reports to regulatory authorities [3]. - The company emphasizes the importance of learning from these experiences to enhance compliance awareness, improve internal control systems, and elevate the quality of information disclosure [3]. Group 3: Company Overview - Tianji Co., Ltd. primarily produces lithium hexafluorophosphate and related fluorochemical products, sodium phosphinate and related phosphochemical products, as well as small household appliances [4]. - As of February 11, the stock price of Tianji Co., Ltd. was reported at 43.96 yuan per share, with a total market capitalization of 22 billion yuan [5]. - As of January 30, the company had over 180,000 shareholders, reflecting a recent increase in shareholder numbers [6][7].

Core Viewpoint - The company emphasizes its commitment to integrity in operations and diligent fulfillment of responsibilities, adhering to relevant accounting standards for annual goodwill impairment testing and accounting treatment of inventory and receivables [2] Group 1 - The company conducts annual goodwill impairment tests in accordance with the relevant requirements of the Accounting Standards for Enterprises [2] - Inventory and receivables are accounted for based on aging, ensuring accurate financial reporting [2] - Legal matters are handled according to the rulings, reflecting the company's adherence to regulatory compliance [2] Group 2 - The company strictly follows relevant regulations and its own Information Disclosure Management Measures to fulfill disclosure obligations [2]

Group 1 - The core viewpoint of the article is that the company, Guoyao Yici, has acknowledged a significant funding requirement in its pharmaceutical distribution segment, which has led to an increase in accounts receivable due to external environmental impacts [1] - The company's goodwill is primarily associated with its pharmaceutical retail segment, and it conducts annual impairment tests on asset groups that include goodwill, in accordance with accounting standards and company policies [1] - The results of the impairment tests determine whether the company needs to recognize any impairment losses, thereby accurately reflecting the value of goodwill assets [1]

证券日报网讯1月21日，国药一致（000028）在互动平台回答投资者提问时表示，根据企业会计准则和 公司会计政策的相关规定，公司每年对包含商誉的资产组进行减值测试，并根据减值测试结果确定是否 需计提减值，如实反映商誉资产价值。 ...

证券日报网讯1月13日，天味食品（603317）在互动平台回答投资者提问时表示，根据《企业会计准则 第8号—资产减值》相关规定，因企业合并所形成的商誉，无论是否存在减值迹象，每年都应当进行减 值测试。公司对商誉进行规范管理，按照相关会计准则进行严格的评估和测试。最近一个经审计的会计 年度未出现商誉减值情形。目前，公司正稳步推进2025年度商誉减值测试工作，如发现存在减值迹象， 公司将严格按照监管规则及时履行信息披露义务。 ...

Group 1 - The core point of the article is that Huabao Co., Ltd. has confirmed its goodwill book value as of September 30, 2025, to be 718 million yuan [2] - The company will conduct a goodwill impairment test at the end of the year in accordance with accounting standards, and the results will determine whether to recognize impairment and the amount [2] - Huabao Co., Ltd. emphasizes its commitment to compliance and ensuring that information disclosure is truthful, accurate, and complete, with detailed financial data and impairment situations to be disclosed in the 2025 annual report [2]

Core Viewpoint - The company announced that it conducts annual impairment tests on goodwill in accordance with accounting standards and policies, with results pending further evaluation after the second half of the year [1] Group 1 - The company stated that it reflects the value of goodwill assets accurately based on the results of impairment tests [1] - Current conditions regarding goodwill are relatively stable, with specific results to be assessed later [1]

Core Viewpoint - The document outlines the internal control system for goodwill impairment testing at Zhejiang Century Huatong Group Co., Ltd, emphasizing the need for compliance with accounting standards and proper disclosure practices. Chapter Summaries Chapter 1: General Provisions - The system is established to regulate the accounting treatment and information disclosure of goodwill impairment in accordance with relevant accounting standards [1]. - The system applies to all subsidiaries with independent legal status that have goodwill matters [1]. - Goodwill is defined as the excess of the cost of an acquired entity over the fair value of its identifiable net assets [1]. - The company must conduct goodwill impairment tests at least annually, regardless of whether impairment indicators are present [1]. - Goodwill impairment matters must be treated separately from performance compensation related to mergers and acquisitions [1]. Chapter 2: Reconfirmation of Goodwill Book Value - Goodwill arising from mergers should be allocated to relevant asset groups based on synergy effects [2]. - The identification of asset groups must ensure they can independently generate cash flows [2]. - Fair value of asset groups must be determined according to relevant accounting standards, and goodwill should be allocated based on the proportion of fair value [2]. Chapter 3: Goodwill Impairment Indicators - Impairment testing should consider both internal and external information, focusing on macroeconomic and industry conditions [4]. - Indicators of impairment include sustained declines in cash flows, adverse changes in industry conditions, and significant changes in the core team [4]. Chapter 4: Goodwill Impairment Testing - The company must evaluate the reasonableness of asset group combinations annually and assess impairment indicators semi-annually [5]. - If impairment indicators are present, the company must first test asset groups without goodwill before testing those with goodwill [6]. - The recoverable amount of asset groups is determined based on the higher of fair value less costs to sell and the present value of future cash flows [6]. Chapter 5: Information Disclosure - The company must disclose all relevant information regarding goodwill impairment in financial reports, ensuring accuracy and completeness [9]. - Disclosure should include details about the asset groups, impairment amounts, testing processes, and any significant changes from previous assessments [10]. Chapter 6: Supplementary Provisions - The system will automatically adapt to changes in external accounting standards [11]. - The finance department is responsible for interpreting and revising the system [11]. - The system will be implemented upon approval by the board of directors [11].